We demonstrate that PDE5 inhibition is associated with atrophy in several subcortical structures, including the thalamus and putamen, regions previously linked with Alzheimer’s disease and impaired global cognitive performance [44]. This evidence concerns the gene PDE5A and early-onset autosomal dominant Alzheimer disease.